Skip to main content

Advertisement

SpringerLink
Log in

Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The objective was to calculate the morbidity rate and medical utilization of interstitial cystitis/painful bladder syndrome (IC/PBS) over 12 years using a nationwide database of Taiwan.

Methods

This was a cohort study of the Longitudinal Health Insurance Database 2010 with new diagnoses of IC/PBS from 2002 through 2013. The morbidity rate was adjusted for age, sex, and calendar date using density methods. Moreover, medical utilization during the study period was measured.

Results

It was observed that the incidence of IC/PBS was 21.8/100,000 in 2002 and 21.1/100,000 in 2013. The prevalence of IC/PBS was 21.8/100,000 in 2002 and 40.2/100,000 in 2013. In 2003, the incidence and prevalence of women was 28.6/100,000 and 63.5/100,000 respectively. The incidence and prevalence of men was 12.3/100,000 and 19.4/100,000 respectively. In 2002, the incidence was 45.5/100,000, 32.4/100,000, and 9/100,000 in the age groups above 65, 40–65, and under 40 years respectively. The prevalence in 2003 was 86.3/100,000, 63.1/100,000, and 16.4/100,000 in age groups above 65, 40–65, and under 40 years respectively. This pattern was similar until 2013. The mean outpatient and inpatient visit time was 4.8 and 1.8 times per year respectively. The mean surgical fee (US$ 246.6 ± 304.5) was 23.6% of the total fee.

Conclusions

The morbidity rate of IC/PBS showed a higher incidence and prevalence in women and older patients. A new drug for the treatment of IC/PBS may be a factor of the peak in the morbidity rate. The increase in medical utilization could be explained by the awareness of physicians and patients seeking medical help.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hanno P, Levin RM, Monson FC, Teuscher C, Zhou ZZ, Ruggieri M, et al. Diagnosis of interstitial cystitis. J Urol. 1990;143(2):278–81.

  2. Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019.

  3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.

  4. Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol. 2002;168(1):139–43. https://doi.org/10.1016/S0022-5347(05)64847-1.

    Article  PubMed  Google Scholar 

  5. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161(2):549–52. https://doi.org/10.1016/S0022-5347(01)61947-5.

    Article  PubMed  CAS  Google Scholar 

  6. Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975;64(2):75–7.

    PubMed  CAS  Google Scholar 

  7. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98–102; discussion 102. https://doi.org/10.1097/01.ju.0000146114.53828.82.

    Article  PubMed  Google Scholar 

  8. Roberts RO, Bergstralh EJ, Bass SE, Lightner DJ, Lieber MM, Jacobsen SJ. Incidence of physician-diagnosed interstitial cystitis in Olmsted County: a community-based study. BJU Int. 2003;91(3):181–5.

    Article  PubMed  CAS  Google Scholar 

  9. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1988;140(1):203–6.

    Article  PubMed  CAS  Google Scholar 

  10. Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology. 2001;57(6 Suppl 1):95–9.

    Article  PubMed  CAS  Google Scholar 

  11. Held PJHP, Wein AJ, Pauly MV, Cann MA. Interstitial cystitis. Epidemiology of interstitial cystitis. 1st ed. New York: Springer; 1990. https://doi.org/10.1007/978-1-4471-3293-6.

    Book  Google Scholar 

  12. Lee M-H. Report from interstitial cystitis/painful bladder syndrome committee. Incont Pelvic Floor Dysfunct. 2009;3(4):119–22.

    Google Scholar 

  13. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. https://doi.org/10.1016/j.juro.2011.03.064.

  14. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906–14.

  15. Lifford KL, Curhan GC. Prevalence of painful bladder syndrome in older women. Urology. 2009;73(3):494–8. https://doi.org/10.1016/j.urology.2008.01.053.

    Article  PubMed  Google Scholar 

  16. Parsons JK, Kurth K, Sant GR. Epidemiologic issues in interstitial cystitis. Urology. 2007;69(4 Suppl):5–8. https://doi.org/10.1016/j.urology.2006.05.050.

    Article  PubMed  Google Scholar 

  17. Parsons CL. Interstitial cystitis: a chronic disease with ever-increasing recognition and prevalence. J Urol. 2005;173(1):6. https://doi.org/10.1097/01.ju.0000148569.76480.bd.

    Article  PubMed  Google Scholar 

  18. Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Willems JJ. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol. 2002;187(5):1395–400.

    Article  PubMed  Google Scholar 

  19. Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Waxell T, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60(4):573–8.

  20. Rothman KJ (2012) Epidemiology: an introduction. New York: Oxford University Press.

    Google Scholar 

  21. Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–5. https://doi.org/10.1016/j.juro.2012.08.088.

    Article  PubMed  Google Scholar 

  22. Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5-6):E136–E155. https://doi.org/10.5489/cuaj.3786.

  23. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53. https://doi.org/10.1016/j.juro.2015.01.086.

    Article  PubMed  Google Scholar 

  24. Wu EQ, Birnbaum H, Mareva M, Parece A, Huang Z, Mallett D, et al. Interstitial cystitis: cost, treatment and co-morbidities in an employed population. Pharmacoeconomics. 2006;24(1):55–65.

  25. Clemens JQ, Meenan RT, Rosetti MC, Kimes T, Calhoun EA. Costs of interstitial cystitis in a managed care population. Urology. 2008;71(5):776–80; discussion 780–1. https://doi.org/10.1016/j.urology.2007.11.154.

  26. Tung A, Hepp Z, Bansal A, Devine EB. Characterizing health care utilization, direct costs, and comorbidities associated with interstitial cystitis: a retrospective claims analysis. J Manag Care Spec Pharm. 2017;23(4):474–82. https://doi.org/10.18553/jmcp.2017.23.4.474.

    Article  PubMed  Google Scholar 

  27. Nickel JC. Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology. 2006;68(4):697–701. https://doi.org/10.1016/j.urology.2006.04.013.

    Article  PubMed  Google Scholar 

  28. Burkman RT. Chronic pelvic pain of bladder origin: epidemiology, pathogenesis and quality of life. J Reprod Med. 2004;49(3 Suppl):225–9.

    PubMed  Google Scholar 

  29. Lee M-H, Lin AT-L, Kuo H-C, Chen Y-F. Clinical characteristic picture and impact of symptoms on quality of life of interstitial cystitis patients in Taiwan. Low Urin Tract Symptoms. 2014;6(1):20–5. https://doi.org/10.1111/luts.12013.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mr Shang-Liang Wu and Mr Hsuan-Hung Lin for help with data collection and management, and Ms Huei-Ching Wu for social event management.

Funding

This study was funded by the Ministry of Health and Welfare, Republic of China. (Project No: 105014).

Author information

Authors and Affiliations

  1. Department of Urology, Taichung Hospital, Ministry of Health and Welfare, No. 199, sec. 1, San-Min Road, Taichung, 40343, Taiwan, Republic of China

    Ming-Huei Lee

  2. Department of Urology, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan, Republic of China

    Ming-Huei Lee

  3. Department of Management Information Systems, Central Taiwan University of Science and Technology, Taichung, 40601, Taiwan

    Kun-Min Chang

  4. Department of Obstetrics and Gynecology, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan, Republic of China

    Kun-Min Chang

  5. Department of Health Services Administration, China Medical University, Taichung, Taiwan, Republic of China

    Wen-Chen Tsai

Authors
  1. Ming-Huei Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun-Min Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Chen Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ming-Huei Lee.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Electronic supplementary material

ESM 1

(DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, MH., Chang, KM. & Tsai, WC. Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome. Int Urogynecol J 29, 1045–1050 (2018). https://doi.org/10.1007/s00192-018-3574-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-018-3574-x

Keywords

Search

Navigation